Epidemiological pattern of breast cancer in iranian women: Is there an ethnic disparity?

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 9, 2012, Pages 4517-4520

  Taheri, Negar Sadat ^a   Nosrat, Sepideh Bakshandeh ^a   Aarabi, Mohsen ^a   Tabiei, Mohammad Naeimi ^a   Kashani, Elham ^a   Rajaei, Siamak ^a   Besharat, Sima ^a   Semnani, Shahryar ^a   Roshandel, Gholamreza ^a  

^a GOLESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Breast cancer; Epidemiology; Ethnic disparity; Iran

Indexed keywords

EID: 84874005011     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.9.4517     Document Type: Article

References (29)

1. Akbari M, Malekzadeh R, Lepage P, et al (2011). Mutations in fanconi anemia genes and the risk of esophageal cancer. Human Genetics, 129, 573-82.
2. Akbari MR, Malekzadeh R, Nasrollahzadeh D, et al (2007). Germline BRCA2 mutations and the risk of esophageal squamous cell carcinoma. Oncogene, 27, 1290-6.
3. Babaee Gh, Feyzi A, Keshavarz M, et al (2005). Study effect of various therapeutic and surgery methods on survival rate in breast cancer. Daneshvar Journal, 59, 19-28.
4. Berry DA, Cronin KA, Plevritis SK, et al (2005). Effect of screening and adjuvant therapy on mortality from breast cancer. N EnglJ Med, 353, 1784-92.
5. Dey S, Soliman AS, Hablas A, et al (2010). Urban-rural differences in breast cancer incidence by hormone receptor status across 6 years in Egypt. Breast Cancer Res Treat, 120, 149-60.
6. Ferlay J, Shin HR, Bray F, et al (2010). GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide, International Agency for Research on Cancer, Lyon.
7. Fouladi N, Amani F, Harghi AS, et al (2011). Five year survival of women with breast cancer in ardabil, north-west of iran. Asian Pac J Cancer Prev, 12, 1799.
8. Fritz A, Percy C, Jack A, et al (2000). International Classification of Diseases for Oncology, Geneva: World Health Oganization.
9. Goya M (2007). Iranian Annual Cancer Registration Report 2005/2006. Tehran: Center for Disease Control and Prevention, Iranian Ministry of Health and Medical Education.
10. Hankey BF, Miller B, Curtis R, et al (1994). Trends in breast cancer in younger women in contrast to older women. JNatl Cancer Inst Monogr, 16, 7-14.
11. Harirchi I, Ebrahimi M, Zamani N, Jarvandi S, Montazeri A (2000). Breast cancer in Iran: a review of 903 case records. Public Health, 114, 143-5.
12. Harirchi I, Karbakhsh M, Kashefi A, et al (2004). Breast cancer in Iran: results of a multi-center study. Asian Pac J Cancer Prev, 5, 24-7.
13. Kamangar F, Malekzadeh R, Dawsey SM, et al (2007). Esophageal cancer in Northeastern Iran: a review. Arch Iran Med, 10, 70-82.
14. Mahboubi E, Kmet J, Cook PJ, et al (1973). Oesophageal cancer studies in the caspian littoral of Iran: the caspian cancer registry. Br J Cancer, 28, 197-214.
15. Mathers C, Fat DM, Boerma JT, et al (2008). The global burden of disease: 2004 update, World Health Organization.
16. Moller T, Anderson H, Aareleid T, et al (2003). Cancer prevalence in Northern Europe: the EUROPREVAL study. Ann Oncol, 14, 946-57.
17. Mousavi SM, Mohaghegghi MA, Mousavi-Jerrahi A, Nahvijou A, Seddighi Z (2006). Burden of breast cancer in Iran: a study of the Tehran population based cancer registry. Asian Pac J Cancer Prev, 7, 571.
18. Naghavi M, Abolhassani F, Pourmalek F, et al (2009). The burden of disease and injury in Iran 2003. Popul Health Metr, 7, 357-62.
19. Pisani P, Bray F, Parkin DM, et al (2002). Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. IntJ Cancer, 97, 72-81.
20. Reynolds P, Hurley SE, Quach AT, et al (2005). Regional variations in breast cancer incidence among California women, 1988-1997. Cancer Causes Control, 16, 139-50.
21. Roshandel G, Sadjadi A, Aarabi M, et al (2012). Cancer incidence in Golestan: Report of an ongoing population-based cancer registry in Iran, 2004-2008. Arch Iran Med, 15, 196-200.
22. Sadjadi A, Nouraie M, Ghorbani A, Alimohammadian M, Malekzadeh R (2009). Epidemiology of breast cancer in the Islamic Republic of Iran: first results from a population-based cancer registry. East Mediterr Health J, 15, 1426-31.
23. Sadjadi A, Nouraie M, Mohagheghi M, et al (2005). Cancer occurrence in Iran in 2002, an international perspective. Asian Pac J Cancer Prev, 6, 359.
24. Semnani S, Roshandel G, Keshtkar A, et al (2008). Annual report of the Golestan Population-based Cancer Registry (GPCR), Peik Reyhan, Gorgan.
25. Semnani S, Sadjadi A, Fahimi S, et al (2006). Declining incidence of esophageal cancer in the Turkmen Plain, eastern part of the Caspian Littoral of Iran: a retrospective cancer surveillance. Cancer Detect Prev, 30, 14-9.
26. Singh GK, Miller BA, Hankey BF, et al (2003). Area socioeconomic variations in US cancer incidence, mortality, stage, treatment, and survival, 1975-1999. NCI cancer surveillance monograph series, 4.
27. Stamenic V, Strnad M (2011). Urban-rural differences in a population-based breast cancer screening program in Croatia. Croat Med J, 52, 76.
28. Yaghmayee S, Banihashemi Gh, Ghorbani R (2007). Study survival rate and effective cause om survival rate in women with breast cancer reffred to Semnan hospital in 1991-2002: using Cox regression. Semnan Univ Med Sci, 9, 111-5.
29. Yavari P, Hislop TG, Bajdik C, et al (2006). Comparison of cancer incidence in Iran and Iranian immigrants to British Columbia, Canada. Asian Pac J Cancer Prev, 7, 86